Skip to main content

Table 1 Participant demographics, co-morbidities, and SARS-CoV-2 antibody results

From: Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)

Subject

Visit 2 Quantitative SARS-CoV-2 Anti-Spike 1-RBD Antibody [U/mL]

(N = 12)

(Subjects who attended Visit 2 & 3)

Reference range

[< 0.8 U/mL]

Visit 3 Quantitative SARS-CoV-2 Anti-Spike 1-RBD Antibody [U/mL]

(N = 26)

(Total subjects who attended Visit 3)

Reference range

[< 0.8 U/mL]

T-cell Immunity Subset

Age

(Visit 1)

[Years]

Gender

Race

Ethnicity

CD4 count

[cells/µL]

HIV

Viral

Load

[copies/mL]

Body Mass Index

[kg/m2]

Co-morbidities

1

 

430

 

68

Male

White

Non-Hispanic

553

0

22.38

Heart Disease, Substance Use Disorder

2

2500

1309

 

56

Male

White

Non-Hispanic

1123

0

29.09

History of Cancer, Heart Disease, Lung Disease, Overweight

3

180

2500

 

50

Male

White

Non-Hispanic

407

0

25.04

History of Cancer, Stroke, Advanced Lung Disease, Smoking history

4

2008

426

T-Cell Subset

63

Male

Black

Non-Hispanic

176

0

29.68

 

5

2500

554

 

55

Male

White

Hispanic

1242

0

27.17

Lung Disease, Substance Use Disorder

6

 

152

 

63

Female

Black

Non-Hispanic

374

0

20.66

Smoking History

7

1101

168

 

64

Male

White

Non-Hispanic

900

0

27.2

Substance Use Disorder

8

 

48

 

61

Male

White

Non-Hispanic

801

0

28.86

Chronic Kidney Disease

9

879

349

 

61

Female

Black

Non-Hispanic

984

0

24.2

 

10

 

577

 

80

Male

Black

Non-Hispanic

718

0

27.25

 

11

2500

1299

 

55

Female

White

Non-Hispanic

359

0

26.63

 

12*

 

29.3

 

66

Male

Black

Non-Hispanic

339

32.9

26.8

Chronic Kidney Disease, Diabetes Mellitus, Heart Disease, Lung Disease

13

2.14

20.6

 

66

Female

Black

Non-Hispanic

103

27.5

25.16

Heart transplant recipient (on tacrolimus), Diabetes Mellitus, Heart Disease, Stroke

14

 

763

 

57

Male

Black

Non-Hispanic

1078

0

31.67

Lung Disease

15

2500

1295

 

63

Female

Black

Non-Hispanic

616

38

24.08

 

16

 

1201

 

56

Male

White

Non-Hispanic

518

0

33.47

Lung Disease

17

250

1363

 

61

Male

White

Non-Hispanic

729

36.7

33.73

Other Cardiovascular Disease, Alcohol use, Substance Use Disorder

18

2500

609

 

58

Male

White

Non-Hispanic

720

0

35.89

Other Cardiovascular Disease, Alcohol use

19

 

47.6

 

60

Male

Black

Non-Hispanic

786

99.7

47.9

Advanced Liver Disease, Diabetes Mellitus, Heart Disease, Other Cardiovascular Disease, Lung Disease

20

 

1020

T-Cell Subset

65

Female

Black

Non-Hispanic

539

0

27.44

Advanced Liver Disease, History of Cancer, Smoking History, Substance Use Disorder

21

 

823

 

61

Male

Black

Non-Hispanic

746

0

29.42

History of Cancer, Heart Disease, Substance Use Disorder

22

 

343

T-Cell Subset

62

Female

White

Hispanic

706

50.6

30.21

History of Cancer, Lung Disease, Smoking History

23

 

196

T-Cell Subset

58

Female

White

Non-Hispanic

1413

0

42.91

Smoking History

24

 

1626

 

64

Male

Black

Non-Hispanic

612

0

38.72

Advanced Liver Disease, History of Cancer, Active Cancer, Diabetes Mellitus

25

2166

315

T-Cell Subset

60

Female

Black

Non-Hispanic

225

0

39.49

Advanced Liver Disease, History of Cancer, Other Cardiovascular Disease, Alcohol Use

26

 

159

 

56

Female

Black

Non-Hispanic

898

0

24.26

Smoking history

Median value

2087

492